Å·ÃÀÈÕb´óƬ

Skip to Main Navigation
BRIEF

World Bank Group¡¯s Operational Response to COVID-19 (coronavirus) ¨C Projects List

Covid19 Vaccine

Å·ÃÀÈÕb´óƬ Group is taking broad, fast action to help developing countries strengthen their pandemic response, increase disease surveillance, improve public health interventions, and help the private sector continue to operate and sustain jobs. At the forefront of the multilateral crisis response, the WBG delivered an unprecedented $204 billion in financial support to public and private sector clients in the first two calendar years of the crisis (CY20-21), of which $135 billion is from IBRD/Å·ÃÀÈÕb´óƬ, $60 billion from IFC and $9 billion from MIGA.

As of June 30, 2022, the World Bank approved operations to support vaccine rollout in 78 countries amounting to $10.1 billion.  Through this, the World Bank Group is working with partners on the largest vaccination effort in history to stop the COVID-19 pandemic.

On April 2, 2020 the first group of projects using the dedicated COVID-19 Fast-Track Facility (also called the COVID-19 Strategic Preparedness and Response Program (SPRP)), amounting to $1.9 billion and assisting 25 countries, was rolled out.

On May 19, 2020 the Bank Group announced its emergency operations to fight COVID-19 have reached 100 developing countries ¨C home to 70% of the world¡¯s population. On October 13, 2020, $12 billion was approved for developing countries to finance the purchase and distribution of COVID-19 vaccines, tests, and treatments for their citizens. 

On June 30, 2021 President Malpass announced the expansion of financing available for COVID-19 vaccine financing to $20 billion over the next 18 months, adding $8 billion to the previously announced $12 billion.

In addition, we are working worldwide to redeploy resources in existing World Bank financed projects, including through restructuring and use of projects¡¯ emergency components as well as contingent financing instruments designed for catastrophes, including pandemics.

 The lists below include:

  • Projects that are supported by the COVID-19 Fast-Track Facility, including support for COVID vaccine acquisition and/or deployment;

  • Projects with support from IBRD and Å·ÃÀÈÕb´óƬ, with components responding to COVID-19, and projects that receive COVID-19 funding through restructuring, redeployment, and reallocation of existing resources.

These lists are updated as projects are processed and approved.

Projects that are supported by the COVID-19 Fast-Track Facility (including support for vaccines)

 
Africa

Burkina Faso
Burundi,
Cabo Verde, Additional financing for vaccines
,
Central African Republic,
Chad

C?te d¡¯Ivoire,
Democratic Republic of Congo
Eswatini,
Ethiopia, , ,
,
The Gambia, Second additional financing for vaccines,  
GhanaAdditional financing,

,
Kenya


Liberia,
,
Malawi,
Mali
Mauritania, ,
,

Niger
Nigeria,
Republic of the Congo
Rwanda, , Second additional financing for vaccines
Sao Tome e Principe
Senegal
Sierra Leone, ,



Togo, ,
Uganda,


 

East Asia and Pacific
Cambodia, , 
Fiji
Indonesia
Kiribati
Lao PDR, Additional financing for vaccines
Marshall Islands
MongoliaAdditional financing for vaccines  
Myanmar
Papua New Guinea
Philippines, ,

Solomon Islands
Timor-Leste
Europe and Central Asia
Albania
Belarus
Bosnia and Herzegovina
Georgia, Additional financing for vaccines
,
Kyrgyz Republic
Moldova
North Macedonia
Serbia
TajikistanAdditional financing, , Additional financing for vaccines
°Õ¨¹°ù°ì¾±²â±ð,
,
Uzbekistan
Latin America and the Caribbean 
Argentina,


Ecuador, Additional financing for vaccines (Spanish)
El Salvador, Additional financing for vaccines (Spanish)

Guyana
Haiti,
Honduras, Additional financing for vaccines (Spanish)
Nicaragua
Panama,
Paraguay

Trinidad and Tobago
Uruguay 
Middle East and North Africa 
Djibouti
Egypt

Jordan
Tunisia, Additional financing for vaccines
Yemen
South Asia 
Afghanistan
Bangladesh
Bhutan
India
Maldives
Nepal
Pakistan
Sri Lanka, , ,




Projects with support from IBRD and Å·ÃÀÈÕb´óƬ, with components responding to COVID-19 and projects with other forms of finance/redeploying of existing projects

  
Africa 

Angola 

Benin

Burkina Faso


Burundi

Cabo Verde

Cameroon

Central African Republic

Chad

Comoros 

Congo, Republic of

Congo, Democratic Republic of

Eastern Africa

Eswatini 

Ethiopia

The Gambia

Ghana 

Guinea

Guinea-Bissau

  • Regional Disease Surveillance Systems Enhancement (REDISSE) Phase II

Kenya

Liberia

  • Regional Disease Surveillance Systems Enhancement Project (REDISSE)
  • REDISSE Phase II

Madagascar

Malawi 

Mali 

Mauritania 

Mozambique

Niger

 

Nigeria

Rwanda

S?o Tom¨¦ and Pr¨ªncipe 

Senegal

Seychelles 

Sierra Leone

Somalia

South Sudan

Sudan

  •  -

Tanzania

Togo

Uganda

Western Africa

Zambia

East Asia and Pacific 

Cambodia 

China

Federated States of Micronesia 

Fiji 

Indonesia

Kiribati

Lao PDR 

Marshall Islands

Mongolia 

Myanmar 

Philippines

Samoa 

Solomon Islands

Tonga

Tuvalu

Vanuatu 

Vietnam

Europe and Central Asia

Albania

Bosnia and Herzegovina

Central Asia

Croatia

Georgia  

Kyrgyz Republic

North Macedonia

Turkey

Ukraine

Uzbekistan

Latin America and the Caribbean 

Argentina 

Bahamas

Belize 

Bolivia 

Brazil

Colombia

Costa Rica 

Dominica 

Dominican Republic

Ecuador

Grenada 

Guatemala

Guyana

Haiti

Honduras

Jamaica

Mexico

  • )
  • )
  • )

Nicaragua

Panama

Peru

Saint Lucia

Saint Vincent and the Grenadines 

Suriname 

Uruguay

Middle East and North Africa 

Djibouti

Egypt, Arab Republic of

Iraq 

Jordan

Lebanon 

Morocco

Tunisia 

West Bank and Gaza 

Yemen 

South Asia 

Afghanistan 

Bangladesh 

Bhutan

India 

Maldives 

Nepal 

Pakistan 

Sri Lanka  (press release for projects below)